Thai law does not permit a foreign manufacturer to hold a device registration or import medical devices commercially without a locally incorporated Thai entity serving as the official registrant and license holder. Who holds that license determines who controls your Thai market access. Most foreign manufacturers discover the consequences of this arrangement only after the relationship with their Thai counterpart has already deteriorated.
The Medical Device Act B.E. 2551 (2008) as amended by B.E. 2562 (2019) establishes a clear principle: only a licensed Thai entity may hold a device registration and import medical devices into Thailand. A foreign manufacturer, regardless of its regulatory standing in its home country or its existing international approvals, cannot hold either license unless it operates a Thai-licensed establishment.
In practice, this means every foreign manufacturer entering the Thai device market must appoint a Thai-incorporated entity as the official registrant. That entity holds the registration in its own name. It is the party legally accountable to the Medical Devices Control Division (MDCD) of Thai FDA for the device's entire lifecycle on the Thai market: registration submission, post-market compliance, variation applications, adverse event reporting, and license renewal.
Foreign-owned Thai subsidiaries qualify as local holders; the foreign manufacturer entity itself does not. The requirement cannot be satisfied by a power of attorney, a contract of appointment, or any other arrangement short of a Thai-incorporated, Thai-licensed legal entity holding the registration in its name.
Before a device registration can be issued in a Thai entity's name, that entity must hold a valid establishment license issued by Thai FDA covering importation and distribution of medical devices. The establishment license and the device registration are separate authorizations. A lapse, suspension, or scope restriction on the establishment license puts every device registered under that entity at risk.
Total cost to obtain an importer establishment license: 16,100 THB, comprising a 100 THB application fee, a 12,000 THB inspection fee, and a 4,000 THB certificate fee. Thai FDA conducts a premises inspection as part of the establishment licensing process. The establishment license must be in place before the device registration application is submitted.
The scope of the establishment license matters. A license that covers distribution but not importation cannot be used to receive commercial shipments. Before appointing any Thai entity as a local holder, confirm that its establishment license is current, valid, and covers the specific activities required for your product and supply chain.
A Letter of Authorization (LOA) from the foreign manufacturer is a required submission document for all device classes: Class 1 listing through Class 4 full license. The LOA formally authorizes the Thai local holder to register and import the device on the manufacturer's behalf.
The scope and language of the LOA are not administrative details. An LOA that grants the Thai holder broad authority over label claims, variation decisions, or licensing structure without corresponding constraints weakens the foreign manufacturer's ability to manage its Thai registration independently of the holder. Once the LOA is granted and the registration is filed in the holder's name, the holder has legal standing over that registration.
LOA scope should be drafted to authorize the specific activities required for registration and importation, not to delegate broader decision-making authority over the product. This distinction becomes relevant when the manufacturer wants to update labeling, submit a variation, or change the local holder arrangement at a later stage.
The most consequential structural risk in Thai device market entry is appointing a distribution partner as the local license holder. The distributor holds the registration in its own name. If the commercial relationship deteriorates, the foreign manufacturer cannot recover its Thai device registration without the distributor's cooperation.
License transfer under the Medical Device Act requires written consent from the current holder. Thai FDA formalized the transfer mechanism through a September 2024 procedural update; transfers with the current holder's written consent can be processed in approximately 2 months. Without that consent, the manufacturer has no administrative remedy short of starting a new registration from scratch under a different holder. The existing registration remains with the distributor until it lapses or is voluntarily surrendered.
This is not an edge case. It is a structural outcome that follows directly from the holder arrangement, and it occurs with enough frequency that experienced Thailand regulatory practitioners treat it as a primary market-entry risk to be addressed at the outset, not a contingency to be managed later.
A foreign manufacturer that has already entered this situation has limited options: negotiate a consent transfer with the current holder, wait for the registration to lapse and re-register under a new holder, or pursue whatever commercial or contractual remedies are available under the original agreement. None of these options are fast or inexpensive.
Foreign manufacturers who want to enter Thailand through a distribution partner without surrendering market access control use a neutral third-party independent license holder. In this structure, the Thai device registration is held by an entity that is not the distributor: a regulatory consultancy, a licensed Thai subsidiary of the manufacturer, or a dedicated regulatory services company that holds licenses on behalf of foreign principals.
The independent holder holds the registration. The distributor handles commercial sales and logistics under a separate distribution agreement. If the distribution relationship ends, the registration stays with the independent holder. The manufacturer can appoint a new distributor without affecting the registration or restarting the regulatory process.
This structure requires the independent holder to hold a valid establishment license covering the relevant device classes, to maintain post-market compliance obligations on the manufacturer's behalf, and to coordinate with the distribution partner for importation and labeling. These are manageable operational requirements. The alternative, rebuilding a Thai device registration after a distributor relationship breaks down, is not.
The local holder relationship is not a clerical arrangement. The holder's regulatory competence, license status, and communication practices directly affect the quality of every Thai FDA interaction and the manufacturer's ability to manage its Thai registration over time.
Confirm before appointment that the prospective holder holds a current, valid establishment license with a scope that covers importation and distribution of the relevant device class. An entity whose license is under renewal, restricted, or does not cover the correct device category cannot legally hold your registration.
The holder must have the internal capability to prepare CSDT dossiers, respond to MDCD queries in Thai, manage variation submissions, and maintain post-market compliance. A holder that outsources all technical work without maintaining oversight is a structural liability.
The commercial agreement with the holder should specify the conditions under which the holder will consent to a license transfer. Securing written transfer consent provisions at appointment is significantly easier than negotiating them after a relationship has broken down.
MDCD correspondence is conducted in Thai. The holder's ability to communicate accurately and promptly in both Thai and English determines how well the foreign manufacturer stays informed of the actual status of its Thai registration at every stage.
VeroPharma Group serves as independent local license holder for foreign medical device manufacturers entering the Thai market. We hold the establishment licenses required for importation and distribution and manage the full regulatory function in-house. The registration is held in our name on behalf of the foreign manufacturer, independently of any distribution arrangement the manufacturer makes in Thailand.
For manufacturers who already have a Thai distribution partner and need only the regulatory holding function separated from the commercial relationship, we structure that cleanly. We hold the license; the distributor moves the product. If the distribution relationship changes, the registration does not.
We assess the holding structure and the LOA scope before any submission document is prepared. Structural decisions made at market entry are difficult and expensive to reverse. We address them at the point when the options are still open.